Search clinical trials for: Discordant Lymphomas
Total 548 results
-
Azienda Ospedaliera Città della Salute e della...UnknownNon-Hodgkin Lymphoma Transformed RecurrentItaly
-
University of AarhusAarhus University HospitalRecruitingPeripheral T-cell Lymphoma | NK/T-Cell LymphomaDenmark
-
H. Lee Moffitt Cancer Center and Research InstituteBeiGene, Ltd.RecruitingFollicular Lymphoma | Marginal Zone Lymphoma | B-Cell LymphomaUnited States
-
Estrella Biopharma, Inc.Eureka Therapeutics Inc.Not yet recruitingLymphoma | Lymphoma, Non-Hodgkin | Non-Hodgkin's Lymphoma | Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | High-grade B-cell Lymphoma | CNS Lymphoma | Lymphomas Non-Hodgkin's B-Cell | Relapsed Non-Hodgkin Lymphoma | Lymphoma, Non-Hodgkins | Large B-Cell Lymphoma and other conditions
-
Stanford UniversityThe Leukemia and Lymphoma SocietyRecruitingFollicular Lymphoma | Burkitt Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Hairy Cell LeukemiaUnited States
-
Canwell Biotech LimitedNot yet recruiting
-
Meyer Children's Hospital IRCCSRecruiting
-
Astellas Pharma Global Development, Inc.RecruitingB-cell LymphomaAustralia
-
Regeneron PharmaceuticalsRecruitingB-Cell Non-Hodgkin Lymphoma (B-NHL)Taiwan, Spain, Korea, Republic of, Thailand, Italy, Malaysia, Turkey, Australia
-
BGI, ChinaShenzhen University General HospitalRecruiting
-
Hangzhou GluBio Pharmaceutical Co., Ltd.RecruitingNon-Hodgkin LymphomaChina
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Not yet recruitingHodgkin Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Positive | Anaplastic Large Cell Lymphoma, ALK-negative | CD30-Positive Diffuse Large B-Cell Lymphoma | Anaplastic Large Cell Lymphoma, T Cell and Null Cell TypeUnited States
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Follicular Lymphoma | Marginal Zone Lymphoma (MZL)Korea, Republic of, Australia, France, Spain, Malaysia, Taiwan, Italy, Poland, United States, Thailand, United Kingdom, Belgium, Turkey, Czechia
-
Huashan HospitalRecruitingKidney Cancer | Positron Emission Tomography | LymphomasChina
-
Lantern Pharma Inc.RecruitingAdvanced Solid Tumor | Relapsed or Refractory LymphomasUnited States
-
Regeneron PharmaceuticalsRecruitingFollicular Lymphoma (FL)Spain, United States, Australia, Turkey, Thailand, United Kingdom, Taiwan, Belgium, Poland, Chile, Italy
-
Bristol-Myers SquibbRecruitingRelapsed/Refractory Non-Hodgkin LymphomaUnited States, Spain, France, Netherlands, Switzerland
-
Centre Henri BecquerelNot yet recruitingPeripheral T Cell LymphomaFrance
-
Regeneron PharmaceuticalsRecruitingDiffuse Large B-cell Lymphoma (DLBCL)United States, Spain, Korea, Republic of, Belgium, Austria, Thailand, Singapore, Italy, France, Australia, Turkey, Poland, Czechia, Chile, United Kingdom, Germany
-
Regeneron PharmaceuticalsRecruitingFollicular Lymphoma (FL)Taiwan, Spain, Israel, United States, Switzerland, Poland, Austria, Turkey, United Kingdom, Czechia, Australia, Italy, Chile
-
Hunan Province Tumor HospitalRecruitingAdvanced Solid Tumors or LymphomasChina
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingCentral Nervous System Tumor | Somatic Mutation | Pediatric Central Nervous System Tumor | Discordant TwinUnited States
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumors | B-cell Non-Hodgkin LymphomasUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingDLBCL - Diffuse Large B Cell LymphomaItaly
-
OncoNano Medicine, Inc.RecruitingLymphoma, Non-Hodgkin | Follicular Lymphoma | Carcinoma in Situ | Mantle Cell Lymphoma | Metastatic Cancer | Bladder Cancer | Skin Cancer | Triple Negative Breast Cancer | Cervix Cancer | Diffuse Large B Cell Lymphoma | Head and Neck Squamous Cell Carcinoma | Tumor, Solid | Tumor Recurrence | Uveal Melanoma, RecurrentUnited States
-
Zhejiang UniversityRecruitingT Lymphoblastic Leukemia/LymphomaChina
-
Aurigene Discovery Technologies LimitedRecruitingRelapsed Advanced LymphomasIndia
-
Affiliated Hospital of Nantong UniversityNot yet recruiting
-
Axter Therapeutics (Beijing) Co., LtdRecruitingRelapsed or Refractory Non-Hodgkin's LymphomaChina
-
University of Michigan Rogel Cancer CenterMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkRecruitingCutaneous T Cell Lymphoma | Fungoides Mycosis Sezary SyndromeUnited States
-
Weill Medical College of Cornell UniversityEpizyme, Inc.; American Society of Clinical Oncology; Applebaum FoundationRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-Cell LymphomaUnited States
-
Immune Oncology Research InstituteAgenus Inc.Recruiting
-
Glenmark Specialty S.A.RecruitingLymphoma | Advanced Solid TumorUnited States, India
-
Tyligand Bioscience (Shanghai) LimitedRecruitingHas a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or LymphomaChina
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingSolid Tumor | Classic Hodgkin LymphomaChina
-
Kymera Therapeutics, Inc.RecruitingAdvanced Solid Tumors | Acute Lymphocytic Leukemia | Lymphomas | Myeloid MalignanciesUnited States
-
Institut Jerome LejeuneRecruiting
-
OSE ImmunotherapeuticsRecruitingDose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or LymphomasLymphoma | Solid Advanced TumorFrance, Belgium
-
Palatin Technologies, IncRecruitingKidney DiseaseUnited States
-
University Hospital, Basel, SwitzerlandNot yet recruitingEBV Lymphoma | Post-transplant Lymphoproliferative Disease (PTLD)Switzerland
-
Regeneron PharmaceuticalsRecruitingB-cell Non-Hodgkins Lymphoma (B-NHL)United States, United Kingdom
-
Baptist Health South FloridaBeiGeneRecruitingPrimary Central Nervous System Lymphoma | Relapsed Cancer | Refractory Cancer | Secondary Central Nervous System LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous... and other conditionsUnited States
-
Patrick C. Johnson, MDAstraZenecaRecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma (DLBCL) | Grade 3b Follicular Lymphoma | Refractory Aggressive B-cell Lymphomas | Aggressive B-cell NHL | De Novo or Transformed Indolent B-cell Lymphoma | DLBCL, Nos Genetic Subtypes | T Cell/Histiocyte-rich Large B-cell Lymphoma and other conditionsUnited States
-
Immunitas TherapeuticsRecruitingFollicular Lymphoma | Colorectal Cancer | Hodgkin Lymphoma | Esophageal Cancer | Small Bowel Cancer | Burkitt Lymphoma | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Diffuse Large B Cell Lymphoma | Head and Neck Squamous Cell Carcinoma | Hormone Receptor Positive Breast Carcinoma | Cutaneous...United States
-
The Lymphoma Academic Research OrganisationRoche Pharma AGRecruitingFollicular LymphomaFrance
-
Antengene (Hangzhou) Biologics Co., Ltd.RecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Mature B-cell Non-Hodgkin LymphomaChina
-
Dren BioNovotechRecruitingAggressive NK Cell Leukemia | Hepatosplenic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Subcutaneous Panniculitis-Like T-Cell Lymphoma | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma | LGLL - Large Granular Lymphocytic Leukemia | Primary Cutaneous T-Cell Lymphoma - Category and other conditionsUnited States, Australia, France, Spain